Aventis Pasteur to increase capacities in France and USA.

http://hoovnews.hoovers.com/fp.asp?layout=displaynews&doc_id=NR20021206670.2_73970002018ad960

Aventis Pasteur to increase capacities in France and USA.

December 6, 2002 7:39am

11/25/2002

Advertisement: Explore Within This Space
	<SCRIPT SRC=http://ad.doubleclick.net/adj/newscenter.com/newscenter;cui=edge336;kw=nonsubscriber;sz=336x280;tile=5;ord=141262?></SCRIPT> <NOSCRIPT> <A HREF="http://ad.doubleclick.net/jump/newscenter.com/newscenter;cui=edge336;kw=nonsubscriber;sz=336x280;tile=5;ord=141262?"> <IMG SRC="http://ad.doubleclick.net/ad/newsnewscenter.com/newscenter;cui=edge336;kw=nonsubscriber;sz=336x280;tile=5;ord=141262?" BORDER=0 WIDTH=336 HEIGHT=280 ALT='Click Here!'>Click Here!</A> </NOSCRIPT>

Aventis Pasteur is to spend $150 M on increasing its vaccines production capacities in France and USA. The company has vaccine plants at Marcy-l'Etoile in France and Swiftwater in Pennsylvania. A vaccines packaging and distribution depot costing EUR 8.5 M and employing staff of around 1000 has been in operation at Val-de-Reuil since Mar 2002. Aventis Pasteur has vaccines capacity in France of 370 M doses/y which is to be increased to 800 M doses/y by 2005. Pasteur Aventis produced 1.3 bn vaccines doses during 2001. These vaccines give protection against nineteen specific diseases including measles, rabies and poliomyelitis.

Financial Times Information Limited - Asia Africa Intelligence Wire

Vaccination News Home Page

ALL INFORMATION, DATA, AND MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS FOR GENERAL INFORMATION PURPOSES ONLY AND IS NOT TO BE CONSTRUED AS REFLECTING THE KNOWLEDGE OR OPINIONS OF THE PUBLISHER, AND IS NOT TO BE CONSTRUED OR INTENDED AS PROVIDING MEDICAL OR LEGAL ADVICE. THE DECISION WHETHER OR NOT TO VACCINATE IS AN IMPORTANT AND COMPLEX ISSUE AND SHOULD BE MADE BY YOU, AND YOU ALONE, IN CONSULTATION WITH YOUR HEALTH CARE PROVIDER.